Literature DB >> 25493374

Potential New Pharmacological Agents Derived From Medicinal Plants for the Treatment of Pancreatic Cancer.

Haniye Azimi1, Ali Asghar Khakshur, Mohammad Abdollahi, Roja Rahimi.   

Abstract

In the present article, we reviewed plants and phytochemical compounds demonstrating beneficial effects in pancreatic cancer to find new sources of pharmaceutical agents. For this purpose, Scopus, PubMed, Web of Science, and Google scholar were searched for plants or herbal components with beneficial effects in the treatment of pancreatic cancer. Data were collected up to January 2013. The search terms were "plant," "herb," "herbal therapy," or "phytotherapy" and "pancreatic cancer" or "pancreas." All of the human in vivo and in vitro studies were included. According to studies, among diverse plants and phytochemicals, 12 compounds including apigenin, genistein, quercetin, resveratrol, epigallocatechin gallate, benzyl isothiocyanate, sulforaphane, curcumin, thymoquinone, dihydroartemisinin, cucurbitacin B, and perillyl alcohol have beneficial action against pancreatic cancer cells through 4 or more mechanisms. Applying their plausible synergistic effects can be an imperative approach for finding new efficient pharmacological agents in the treatment of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25493374     DOI: 10.1097/MPA.0000000000000175

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  7 in total

1.  Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells.

Authors:  Jia Ma; Fanpeng Zeng; Cong Ma; Haijie Pang; Binbin Fang; Chaoqun Lian; Bin Yin; Xueping Zhang; Zhiwei Wang; Jun Xia
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

2.  Perillyl alcohol for pediatric TP53- and RAS-mutated SHH-medulloblastoma: an in vitro and in vivo translational pre-clinical study.

Authors:  Marcela de Oliveira Silva; Graziella Ribeiro de Sousa; Sarah Capelupe Simões; Patrícia Nicolucci; Edwin Tamashiro; Fabiano Saggioro; Ricardo Santos de Oliveira; María Sol Brassesco
Journal:  Childs Nerv Syst       Date:  2021-04-22       Impact factor: 1.475

Review 3.  Curcumin AntiCancer Studies in Pancreatic Cancer.

Authors:  Sabrina Bimonte; Antonio Barbieri; Maddalena Leongito; Mauro Piccirillo; Aldo Giudice; Claudia Pivonello; Cristina de Angelis; Vincenza Granata; Raffaele Palaia; Francesco Izzo
Journal:  Nutrients       Date:  2016-07-16       Impact factor: 5.717

4.  Curcumin enhances anti‑cancer efficacy of either gemcitabine or docetaxel on pancreatic cancer cells.

Authors:  Pan Liu; Qian Ying; Huan Liu; Si-Qi Yu; Lu-Ping Bu; Liang Shao; Xin-Yi Li
Journal:  Oncol Rep       Date:  2020-08-03       Impact factor: 3.906

Review 5.  Dietary Polyphenols in Cancer Chemoprevention: Implications in Pancreatic Cancer.

Authors:  Anita Thyagarajan; Andrew S Forino; Raymond L Konger; Ravi P Sahu
Journal:  Antioxidants (Basel)       Date:  2020-07-23

Review 6.  Quercetin Impact in Pancreatic Cancer: An Overview on Its Therapeutic Effects.

Authors:  Parina Asgharian; Abbas Pirpour Tazehkand; Saiedeh Razi Soofiyani; Kamran Hosseini; Miquel Martorell; Vahideh Tarhriz; Hossein Ahangari; Natália Cruz-Martins; Javad Sharifi-Rad; Zainab M Almarhoon; Alibek Ydyrys; Ablaikhanova Nurzhanyat; Arailym Yessenbekova; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-11-03       Impact factor: 6.543

Review 7.  Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer.

Authors:  Puvanesswaray Ramakrishnan; Wei Mee Loh; Subash C B Gopinath; Srinivasa Reddy Bonam; Ismail M Fareez; Rhanye Mac Guad; Maw Shin Sim; Yuan Seng Wu
Journal:  Acta Pharm Sin B       Date:  2019-11-14       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.